News
Lim EHT, et al. Regional comparison of efficacy and safety for vilobelimab in critically ill, invasively mechanically ventilated COVID-19 patients. BMJ Open Respir Res. 2025;12 (1):e002206. Ward PA, ...
Sepsis, which used to be known as septicemia or blood poisoning, is a leading cause of death among COVID-19 patients. It represents the immune system’s toxic overreaction to an infection.
"Early-warning system for sepsis shown to improve survival rates and cut hospital stays." ScienceDaily. ScienceDaily, 24 August 2021. <www.sciencedaily.com / releases / 2021 / 08 / 210824135353.htm>.
The Lancet Respiratory Medicine, a peer-reviewed journal, published the results of the PANAMO trial, one of the largest, global, 1:1 randomized, placebo-controlled Phase III studies conducted in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results